NCT04724720View on ClinicalTrials.gov

Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

May 3, 2021

Study Completion Date

June 30, 2022

Conditions

Covid-19

Interventions

DRUG

Famotidine

Standard or care treatment plus prescribed famotidine

DRUG

Placebo

Standard of care treatment plus placebo

Trial Locations (1)

11042

Northwell Health, Lake Success

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

collaborator

Cold Spring Harbor Laboratory

OTHER

lead

Northwell Health

OTHER